Rare diseases
Investigational molecules
Locations
Back to Italy153 clinical trials in Messina, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Phase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
ItalyItalyNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
ItalyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
ItalyComparing the effectiveness of nepafenac and dexamethasone sodium phosphate for treating eye inflammation after cataract surgery
ItalyStudy of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature
ItalyA study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy
ItalyPhase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer
ItalyA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
ItalyItalyA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and lung cancer treatments.
Research emphasizes targeted therapies and immunotherapy combinations for improved patient outcomes.
Clinical studies investigating treatments for Crohn's disease, ulcerative colitis, and pyoderma gangrenosum, focusing on novel therapeutic approaches.
Emphasis on developing targeted biological therapies for chronic inflammatory conditions.
Groundbreaking research on Rett Syndrome, transthyretin amyloidosis, and polycystic kidney disease, exploring innovative treatment options.
Focus on developing targeted treatments for rare genetic conditions and improving patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
